Comparing rivaroxaban and enoxaparin for preventing blood clots in obese patients undergoing weight loss surgery
Official title: Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Morbidly Obese Patients Undergoing Bariatric Surgery: An open_label Randomized Controlled Trial
Run by Alexandria University · NCT06689241 · Data updated 2026-11-12
This study tests whether the blood thinner rivaroxaban works better than enoxaparin to prevent blood clots in obese patients having weight loss surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 60 Years |
| Sex | All |
| Enrollment | 162 (estimated) |
| Sponsor | Alexandria University Academic / other |
| Locations | 1 site (Alexandria) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | December 1, 2025 |
| Study ends | May 1, 2026 |
| Registry record updated | April 22, 2025 |
| Trial ID | NCT06689241 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 20-60 years with a BMI between 35-50 kg/m² who are classified as ASA physical status class I to III.
✕Probably not a fit
Patients with severe cardiac disorders, chronic renal failure, liver cirrhosis, or major psychological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of rivaroxaban compared to enoxaparin for the prevention of venous thromboembolism (VTE) in morbidly obese patients who are candidates for bariatric surgery. The study is an open-label randomized controlled trial that aims to determine which medication is more effective in reducing the risk of post-operative blood clots. Given the rising prevalence of obesity and the associated risks of VTE, this research addresses a critical public health issue. Participants will be monitored for VTE incidence following their surgical procedures to assess the outcomes of each treatment.
Why it matters
Potential benefit: If successful, this study could lead to improved prophylactic strategies for preventing life-threatening blood clots in obese patients undergoing bariatric surgery.
How similar studies have gone: Other studies have explored the use of anticoagulants for VTE prevention in surgical patients, but this specific comparison of rivaroxaban and enoxaparin in the context of bariatric surgery is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 20-60 years, both sexes. * ASA physical status class I to III. * BMI 35-50 kg/m² Exclusion Criteria: * Severe cardiac disorder * chronic renal failure * liver cirrhosis * major psychological disorder
Where it's running
-
Alexandria University
Alexandria, Egypt Recruiting
Study contacts
- Principal investigator: sarah m elgamal, MD — Alexandria University
- Study coordinator: sarah m elgamal, MD
- Email: sarahelgamal1990@yahoo.com
- Phone: 01005496440
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Examining gut microbiota changes in patients undergoing metabolic surgery
This study is testing how metabolic surgery affects gut bacteria and heart health in patients, especially focusing on the African American community, over the next 10 years.
-
Factors that determine long-term success after bariatric surgery
We will see which patient and surgical factors are linked to lasting weight loss in people who had bariatric surgery at least five years ago.
-
TSBL-based vs BMI-based limb length in one-anastomosis gastric bypass
This trial tests whether calculating the biliopancreatic limb length by total small bowel length (TSBL) helps weight loss and safety more than using standard BMI-based lengths in adults undergoing a single-center OAGB for obesity.
-
Transcutaneous Nerve Stimulation to Help Breathing After Bariatric Surgery
A randomized trial tests whether a skin-placed nerve stimulator can reduce diaphragmatic dysfunction after bariatric surgery in people with obesity.
-
Stress response with desflurane versus opioid-free TIVA during weight-loss surgery
This study will test whether adding the inhaled anesthetic desflurane to opioid-free anesthesia changes the body's perioperative stress response in people having bariatric (weight-loss) surgery.
-
Gut stool tests after sleeve vs gastric bypass
This study tests whether routine stool tests can reveal changes in gut function six months after sleeve gastrectomy or gastric bypass in adults with morbid obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.